Manufacturing, Drug Products

When FDA reviewed PDA's Technical Report No. 34 about isolator systems, significant differences of opinion between the organizations came to light.

Semisolid dosage forms are advantageous in terms of their easy application, rapid formulation, and ability to topically deliver a wide variety of drug molecules.

Low levels of some microorganisms that are present in oral solid dosage forms are unlikely to present a risk to patients. The amount of water activity in these products can help determine when microbiological testing should be conducted.

A limited number of container sizes, dispensing lanes, computerized tracking, and polyethylene mailing bags are just a few of the new elements of packaging launched at one company's automated pharmacy facility.

NIR quality control technology, relatively new to the pharmaceutical industry, could revolutionize processing and packaging.

Manufacturers are gearing up to make labeling chnges required on most over&#173the&#173counter pharmaceutical products.

The latest developments in packaging technology made a strong showing at the 2001 Interphex exhibition.

Significant advances have shaped the past 25 years in the pharmaceutical industry, and the next 25 years will be no exception.

In the past three decades, several industry-altering episodes have changed the face of pharmaceutical packaging.

Cyclic olefin copolymer (COC) resins are showing a number of benefits that could propel their usage in syringe bodies, blister packs, and other packaging components.